ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

ACS Says 41 Percent Survive 5 Years

January 2, 1981

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006